Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nazlı Dizman(City Of Hope National Medical Center), Sumanta K. Pal(City of Hope)
Cited by 453
Related Papers
Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers
|JAMA Oncology|2019|302
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
|Journal for ImmunoTherapy of Cancer|2018|184
Papillary carcinoma of the breast: an overview
|Breast Cancer Research and Treatment|2010|142
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
|Nature Reviews Clinical Oncology|2021|140
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
|Cancer Discovery|2024|137